Skip to content

Achieve Life Sciences ACHV Ratios & Valuation

FY'25FY'24FY'23FY'22
Returns
Return on equity-257.7%-233%-132pp
Return on assets-135.9%+1.4pp-137.3%-16.5pp-120.9%-11.5pp-109.3%-33.8pp
Return on invested capital-852.7%
Liquidity
Current ratio4.4×-1.1×5.5×+4.6×0.8×-0.4×1.3×-8.5×
Quick ratio4.4×-1.1×5.5×+4.6×0.8×-0.4×1.3×-8.5×
Cash ratio2.3×+0.4×1.9×+1.2×0.7×-0.4×1.1×-8.3×
Leverage
Debt-to-equity0.2×+0.2×+1.9×
Debt-to-assets0.1×+0.1×-0.9×0.9×+0.3×0.5×+0.5×
Interest coverage-65.7×-48.5×-17.3×-7.8×-9.5×+13.2×-22.7×
Per Share
Book value per share$0.49-24.2%$0.65+993%-$0.07-109%$0.78-77.3%
Valuation
Market capitalization$585.16M+404%$121.05M+38.8%$87.2M+98.9%$43.85M-40.4%
Enterprise value$562.71M+439%$108.42M+22.7%$88.39M+151%$35.27M+15.3%
Price / book54.8×+43.5×5.8×5.3×+2.7×
Free cash flow yield-18.7%
Earnings yield-8.9%+30.8pp-32.9%+1.3pp-34.2%+62.4pp-96.6%-51.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Achieve Life Sciences's ratios come from?
Every ratio is computed from Achieve Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.